Stay updated with breaking news from Durable Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mind Medicine Inc. , , a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders, announced today that it will present detailed results from its...
A key opinion leader explores the integration of bispecifics into MM therapy regimens.
Rafael Fonseca, MD, discusses findings from the PERSEUS trial presented in December at ASH 2023.
Laurie Sehn, MD, discusses recent data on zanubrutinib, a BTK inhibitor, as third-line and beyond therapy for FL.
Read trending news, stories and press releases from PMN Wire News about Canadian and international businesses.